4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-028858
Chief Commercial Officer gave up 1,153 shares (to pay taxes)
- Chief Commercial Officer acquired 4,050 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fair Brett Chief Commercial Officer | 2018-05-07 | Option exercise | +4,050 | 7,191 | D: show line 1 in the form | ||
| Fair Brett Chief Commercial Officer | 2018-05-07 | Shares withheld for taxes | −1,153 | $18.10 | $20,869 | 6,038 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Fair Brett Chief Commercial Officer | 2018-05-07 | Option exercise · Restricted Stock Units | −4,050 | 3,038 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…